// App-Quantinova.ai

3904 : Preliminary Results Of a Pharmacokinetic Study Of Intravenous Asparaginase Erwinia Chrysanthemi Following Allergy To E Coli-Derived Asparaginase In Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia Or Lymphoblastic Lymphoma

Researchers

Presenter

  • Lynda M. Vrooman

Principal Investigators

  • Ivan I. Kirov

  • Zoann E. Dreyer

  • Paul V. Plourde

  • Lewis B. Silverman

  • Michael Kelly

  • Nobuko Hijiya

  • Patrick Brown

  • Richard A. Drachtman

  • Yoav H Messinger

  • A. Kim Ritchey

  • Gregory A. Hale

  • Kelly Maloney

Medical Centers

  • Jazz Pharmaceuticals, Palo Alto, CA

  • All Childrens Hospital, St. Petersburg, FL

  • Dana-Farber Cancer Institute, Children's Hospital, Boston, MA

  • Children's Hosp of Pittsburgh of UPMC, Pittsburgh, PA

  • Children's Hospital Colorado, Aurora, CO

  • Ann & Robert H. Lurie Children's Hosp. of Chicago and Northwestern University Feinberg School of Medicine, Chicago, IL.

  • Children's Hospital of Orange County, Orange, CA

  • Children's Hospitals and Clinics of Minnesota, Minneapolis, MN

  • Pediatric Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD

  • Dana-Farber Cancer Institute, Children's Hospital, Boston, MA

  • Pediatrics, Childrens Hospital of Wisconsin/Medical College of Wisconsin, Milwaukee, WI

  • Rutgers Cancer Institute of New Jersey, New Brunswick, NJ

  • Texas Childrens Cancer Center, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Transient Ischemic Attack

  • Transient ischemic attack

  • Hyperglycemia

  • Pancreatitis

  • Neutropenia

  • Venous thrombosis

  • Lymphomas

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • asparaginase Erwinia chrysanthemi

  • Erwinase

  • Pegaspargase

  • Oncaspar

  • Asparaginase

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved